XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke (XILO-FIST)
Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack
Sponsor: NHS Greater Glasgow and Clyde
Listed as NCT02122718, this PHASE4 trial focuses on Ischaemic Stroke and remains completed. Sponsored by NHS Greater Glasgow and Clyde, it has been updated 9 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 4 earlier versions
-
Oct 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Oct 2019 [monthly]
Recruiting PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Mar 2018 [monthly]
Recruiting PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NHS Greater Glasgow and Clyde
- University of Glasgow
For direct contact, visit the study record on ClinicalTrials.gov .